Business Context and Reporting Period
This Form 8-K Current Report from Zymeworks Inc. (ZYME) covers the date of March 31, 2026. The filing announces a significant executive leadership change, specifically the appointment of a new Chief Financial Officer (CFO) and the conclusion of the interim tenure of the previous officer.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and employment terms.
- Base Salary (New CFO): $520,000 annually.
- Signing Bonus: $52,000.
- Discretionary Bonus: Up to 45% of base salary.
- Equity Grants: 178,000 stock options and 169,000 restricted stock units (RSUs) total.
Material Changes
The primary material change is the appointment of Ms. Kristin Stafford as Executive Vice President and Chief Financial Officer, effective April 1, 2026. Concurrently, Mr. Kenneth Galbraith ceased serving as interim CFO, principal financial officer, and principal accounting officer, though he retains his roles as Chair, President, and CEO.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. The primary risk disclosure relates to the employment agreement terms, specifically:
- Severance Provisions: In the event of termination without cause, Ms. Stafford is eligible for 12 months of base salary (increasing to a maximum of 18 months after the fourth year of service).
- Change of Control: Termination without cause within 12 months of a Change of Control triggers 18 months of base salary, continued health benefits, and full acceleration of unvested equity.
- Excise Tax: The agreement includes a "best net" provision to maximize after-tax benefits if payments are subject to Section 280G excise taxes, but no tax gross-up is provided.
Investor Verification Checklist
- Verify the vesting schedules for the 178,000 options and 169,000 RSUs granted to the new CFO.
- Review the full text of the Employment Agreement (Exhibit 10.1) for specific performance goals tied to the discretionary bonus.
- Confirm the impact of the new CFO's appointment on the company's internal controls and financial reporting processes.
- Check the press release (Exhibit 99.1) for any additional strategic context regarding the leadership transition.